Voxelotor improves hemoglobin levels in sickle cell disease

(HealthDay)—For individuals with sickle cell disease, 1,500 mg of voxelotor increases hemoglobin levels and reduces the incidence of worsening anemia compared with placebo, according to a study published in the June 14 issue of the New England Journal of Medicine.

* This article was originally published here